Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
Digiday+ Research: The state of social media marketing (spoiler: Instagram came out on top in 2024)
Digiday+ Research surveyed brand, retailer and agency professionals in 2024 to rank platforms based on usage and spending.
How VaynerMedia is optimizing its supply path optimization practices
The agency plans to increase its cadence of SPO-related check-ins with clients and ad tech firms, particularly supply-side platforms.
Channel Factory has partnered with Canaccord Genuity as ad tech’s M&A-train gathers steam
The contextual targeting parnters with advisory firm seeking investment to further growth.